What Happened to Jay Enhypen? Jay from ENHYPEN Collaborates with GLAY on New Single
by
Updated Jun 28, 2024
What Happened to Jay Enhypen?
JAY from ENHYPEN has experienced knee pain after a recent concert in Japan. Due to this, he's receiving medical care and has been advised to avoid excessive movement, including dancing and performing. As a result, he won't be participating in choreography during upcoming events, including tonight's concert and the 2024 MUSIC CORE IN JAPAN.
Despite this, he's determined to attend scheduled activities. His health is being prioritized, and efforts are underway to help him recover fully so he can return to performing for his fans soon. For updates, checking BELIFT LAB or ENHYPEN's official channels would provide the latest information on his condition and schedule adjustments.
Jay from ENHYPEN Collaborates with GLAY on New Single
Jay from ENHYPEN has joined forces with the legendary Japanese rock band GLAY for an exciting new song called "whodunit-GLAY × JAY(ENHYPEN)-." This song is part of GLAY’s special 30th-anniversary celebration. Released at midnight, the track quickly gained worldwide attention.
Jay impressed fans by writing Japanese lyrics for the first time and starring in the music video alongside GLAY's lead singer, TERU. In the video, there's a memorable scene where Jay and TERU have a tug-of-war over a microphone, showcasing their great chemistry.
https://www.instagram.com/p/C6JJR0iLH_L/
Enhypen's Upcoming Debut of "Fatal Trouble"
ENHYPEN, including member Jay, is gearing up to release their new song "Fatal Trouble" from their special album called Dark Moon. They will perform this song for the first time on the popular music show "M Countdown" on Mnet.
This debut is a big moment for ENHYPEN as it showcases their latest music and style to a wide audience. Fans are eagerly anticipating the performance and the release of "Fatal Trouble," expecting it to continue ENHYPEN's success in the music industry. This upcoming debut marks another step forward for Jay and the rest of ENHYPEN as they continue to grow in popularity and talent.
Who is Jay Enhypen?
Jay, also known as Park Jong-seong, is a member of the South Korean boy group ENHYPEN. Jay is of Korean-American descent. He gained fame through the reality show "I-LAND" in 2020, where he finished 2nd and secured a spot in ENHYPEN.
Jay serves as a vocalist and dancer in the group, showcasing his talents since their debut on November 30, 2020. Managed by BELIFT LAB, ENHYPEN has quickly become popular in the K-pop scene and internationally. Jay's stage name is written as 제이 in Korean and ジェイ in Japanese. His fans affectionately call him by nicknames like "Angry Bird" and "Jjongsaeng."
https://www.instagram.com/p/C6gGsdPLHmT/
Attribute |
Details |
Full Name | Park Jong-seong |
Stage Name | Jay |
Birth Date | April 20, 2002 |
Age | 22 years old |
Birth Place | Seattle, Washington, United States |
Nationality | Korean-American |
Height | 176 cm (5’9”) |
Weight | 60 kg (132 lbs) |
Blood Type | B |
Zodiac Sign | Aries-Taurus cusp |
MBTI | ENTP |
Occupation | Rapper, Singer |
Debut | November 30, 2020 |
Years Active | 2020-present |
Agency | BELIFT LAB |
Group Association | ENHYPEN |
Position in Group | Vocalist, Dancer |
Nicknames |
Angry Bird, Jjongsaeng |
Age
Jay from ENHYPEN is 22 years old. He was born on April 20, 2002, in Seattle, Washington, USA.
Career
Jay's career began when he participated in the reality survival show "I-LAND" in 2020. During the show, he trained for two years and eleven months and competed against other trainees. Jay impressed the judges and audience with his skills, ultimately finishing in 2nd place and securing a spot in the newly formed boy group ENHYPEN. The group debuted on November 30, 2020, under BELIFT LAB.
Since then, Jay has been active as a vocalist and dancer in ENHYPEN, contributing to their rapid rise in the K-pop industry. The group has released several successful albums and performed in various concerts and events worldwide. Jay continues to grow his career, showcasing his talent and passion for music.